Prognostic value of dynamic electrocardiographic T wave changes in non-ST elevation acute coronary syndrome.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27112175)

Published in Heart on April 25, 2016

Authors

Bradley Sarak1, Shaun G Goodman2, Raymond T Yan3, Mary K Tan4, Ph Gabriel Steg5, Nigel S Tan1, Keith A A Fox6, Jacob A Udell7, David Brieger8, Robert C Welsh9, Chris P Gale10, Andrew T Yan1, Canadian Acute Coronary Syndromes I, and Global Registry of Acute Coronary Events (GRACE) Investigators

Author Affiliations

1: St Michael's Hospital, Toronto, Canada University of Toronto, Toronto, Canada.
2: St Michael's Hospital, Toronto, Canada University of Toronto, Toronto, Canada Canadian Heart Research Centre, Toronto, Canada.
3: University of Toronto, Toronto, Canada.
4: Canadian Heart Research Centre, Toronto, Canada.
5: Département Hospitalo-Universitaire FIRE, Université Paris Diderot, AP-HP, Hôpital Bichat, and INSERM U-1148, Paris, France.
6: Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
7: Cardiovascular Division, Department of Medicine, Women's College Hospital and Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada.
8: Department of Cardiology, Concord Hospital, University of Sydney, Sydney, New South Wales, Australia.
9: Mazankowski Alberta Heart Institute, University of Alberta Hospital, Canadian VIGOUR Centre, Edmonton, Alberta, Canada.
10: Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.

Articles by these authors

Radial versus femoral access for percutaneous coronary intervention in ST-elevation myocardial infarction patients treated with fibrinolysis: Results from the randomized routine early invasive clinical trials. Cardiovasc Revasc Med (2016) 1.38

Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score. BMJ Open (2014) 0.92

Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis. Eur Heart J (2015) 0.90

Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trial. Am Heart J (2015) 0.87

International comparisons of acute myocardial infarction. Lancet (2014) 0.79

High-grade atrioventricular block in acute coronary syndromes: insights from the Global Registry of Acute Coronary Events. Eur Heart J (2014) 0.78

Prognostic burden of heart failure recorded in primary care, acute hospital admissions, or both: a population-based linked electronic health record cohort study in 2.1 million people. Eur J Heart Fail (2016) 0.76

Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non-ST-Segment Elevation Acute Coronary Syndrome. Clin Chem (2017) 0.75

The Cancer Patient and Cardiology. Eur J Heart Fail (2020) 0.75

Effect of prior clopidogrel use on outcomes in medically managed acute coronary syndrome patients. Heart (2016) 0.75

Impact of co-morbid burden on mortality in patients with coronary heart disease, heart failure, and cerebrovascular accident: a systematic review and meta-analysis. Eur Heart J Qual Care Clin Outcomes (2017) 0.75

Temporal trends in all-cause mortality according to smoking status: Insights from the Global Registry of Acute Coronary Events. Int J Cardiol (2016) 0.75

Prognostic implications of prominent R wave in electrocardiographic leads V1 or V2 in patients with acute coronary syndrome. Am J Cardiol (2014) 0.75

Electrocardiographic Findings in Patients With Acute Coronary Syndrome Presenting With Out-of-Hospital Cardiac Arrest. Am J Cardiol (2017) 0.75

Why Are Outcomes Different for Registry Patients Enrolled Prospectively and Retrospectively? Insights from the Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF). Eur Heart J Qual Care Clin Outcomes (2017) 0.75

A cluster randomized trial of objective risk assessment versus standard care for acute coronary syndromes: Rationale and design of the Australian GRACE Risk score Intervention Study (AGRIS). Am Heart J (2015) 0.75

Baseline characteristics, adenosine diphosphate receptor inhibitor treatment patterns, and in-hospital outcomes of myocardial infarction patients undergoing percutaneous coronary intervention in the prospective Canadian Observational AntiPlatelet sTudy (COAPT). Am Heart J (2016) 0.75

GRACE risk score: Sex-based validity of in-hospital mortality prediction in Canadian patients with acute coronary syndrome. Int J Cardiol (2017) 0.75

Clinical Characteristics, Management, and Outcomes of Acute Coronary Syndrome in Patients With Right Bundle Branch Block on Presentation. Am J Cardiol (2015) 0.75

Cardiovascular Risk Factors and In-hospital Mortality in Acute Coronary Syndromes: Insights From the Canadian Global Registry of Acute Coronary Events. Can J Cardiol (2015) 0.75